MolNFT v1 · #73618 · protein
Crystal structure of archaeoglobus fulgidus NEP1 bound to S- adenosylhomocysteine
3O7B · Ribosome biogenesis NEP1 RNA methyltransferase: “Crystal structure of archaeoglobus fulgidus NEP1 bound to S- adenosylhomocysteine”. X-ray diffraction, 2 ligands (TYR, SAH), 1 pocket (best druggability 0.61). MolNFT v1 #73618 on…
- PDB
- 3O7B
- Type
- protein
- Length
- 216 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Ribosome biogenesis NEP1 RNA methyltransferase
- UniProt
- O29524
- Ligands
- TYR, SAH
- Pockets
- 1 · best druggability 0.61
Structure
x-ray diffraction · 1 distinct chain · 38% helix, 24% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Ribosome biogenesis NEP1 RNA methyltransferase | protein | 216 | 38% helix, 24% strand | O29524 |
Ligands and binding sites
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 204 | 0.61 | 0.82 | 28 | SAH |
Compared structures
- 3O7B · Crystal structure of Archaeoglobus Fulgidus Nep1 bound to S-adenosylhomocysteine · the same entry in another collection · chain A against A, TM-score 1.00
- O29524 · AlphaFold monomer V2.0 prediction for ribosomal RNA small subunit methyltransferase NEP1… · a predicted model of the same protein · chain A against A, TM-score 0.99
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O29524
- Elsewhere: RCSB PDB 3O7B · PDBe 3O7B · UniProt O29524
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.